136 related articles for article (PubMed ID: 36089417)
1. Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer.
Martini C; Logan JM; Sorvina A; Gordon C; Beck AR; S-Y Ung B; Caruso MC; Moore C; Hocking A; Johnson IRD; Li KL; Karageorgos L; Hopkins AM; Esterman AJ; Huzzell C; Brooks RD; Lazniewska J; Hickey SM; Bader C; Parkinson-Lawrence E; Weigert R; Sorich MJ; Tewari P; Martin C; O'Toole S; Bates M; Ward M; Mohammed B; Keegan H; Watson W; Prendergast S; Heffernan S; NiMhaolcatha S; O'Connor R; Malone V; Carter M; Ryan K; Brady N; Clarke A; Sokol F; Prabhakaran S; Stahl J; Klebe S; Samaratunga H; Delahunt B; Selemidis S; Moretti KL; Butler LM; O'Leary JJ; Brooks DA
Pathology; 2023 Feb; 55(1):40-51. PubMed ID: 36089417
[TBL] [Abstract][Full Text] [Related]
2. Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread.
Sorvina A; Martini C; Prabhakaran S; Logan JM; S-Y Ung B; Moore C; Johnson IRD; Lazniewska J; Tewari P; Malone V; Brooks RD; Hickey SM; Caruso MC; Klebe S; Karageorgos L; O'Leary JJ; Delahunt B; Samaratunga H; Brooks DA
Pathology; 2023 Oct; 55(6):792-799. PubMed ID: 37422404
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.
Logan JM; Hopkins AM; Martini C; Sorvina A; Tewari P; Prabhakaran S; Huzzell C; Johnson IRD; Hickey SM; Ung BS; Lazniewska J; Brooks RD; Moore CR; Caruso MC; Karageorgos L; Martin CM; O'Toole S; Bogue Edgerton L; Ward MP; Bates M; Selemidis S; Esterman A; Heffernan S; Keegan H; Ní Mhaolcatha S; O'Connor R; Malone V; Carter M; Ryan K; Clarke A; Brady N; Klebe S; Samaratunga H; Delahunt B; Sorich MJ; Moretti K; Butler LM; O'Leary JJ; Brooks DA
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370825
[TBL] [Abstract][Full Text] [Related]
4. A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells.
Sharpe B; Alghezi DA; Cattermole C; Beresford M; Bowen R; Mitchard J; Chalmers AD
Prostate; 2017 May; 77(13):1312-1324. PubMed ID: 28744948
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer.
Martini C; Logan JM; Sorvina A; Prabhakaran S; Ung BSY; Johnson IRD; Hickey SM; Brooks RD; ; Caruso MC; Klebe S; Karageorgos L; O'Leary JJ; Delahunt B; Samaratunga H; Brooks DA
Virchows Arch; 2023 Sep; ():. PubMed ID: 37704825
[TBL] [Abstract][Full Text] [Related]
6. Increased SNAIL expression and low syndecan levels are associated with high Gleason grade in prostate cancer.
Poblete CE; Fulla J; Gallardo M; Muñoz V; Castellón EA; Gallegos I; Contreras HR
Int J Oncol; 2014 Mar; 44(3):647-54. PubMed ID: 24424718
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy.
Shariat SF; Svatek RS; Kabbani W; Walz J; Lotan Y; Karakiewicz PI; Roehrborn CG
BJU Int; 2008 Jan; 101(2):232-7. PubMed ID: 17868422
[TBL] [Abstract][Full Text] [Related]
8. Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression.
Lazniewska J; Li KL; Johnson IRD; Sorvina A; Logan JM; Martini C; Moore C; Ung BS; Karageorgos L; Hickey SM; Prabhakaran S; Heatlie JK; Brooks RD; Huzzell C; Warnock NI; Ward MP; Mohammed B; Tewari P; Martin C; O'Toole S; Edgerton LB; Bates M; Moretti P; Pitson SM; Selemidis S; Butler LM; O'Leary JJ; Brooks DA
Sci Rep; 2023 Aug; 13(1):13489. PubMed ID: 37596305
[TBL] [Abstract][Full Text] [Related]
9. Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling.
Holmes RM; Yi Z; De Filippis E; Berria R; Shahani S; Sathyanarayana P; Sherman V; Fujiwara K; Meyer C; Christ-Roberts C; Hwang H; Finlayson J; Dong LQ; Mandarino LJ; Bajaj M
Diabetologia; 2011 Aug; 54(8):2122-31. PubMed ID: 21562756
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-1 expression in prostate cancer and its value as biomarker for disease progression.
Brimo F; Vollmer RT; Friszt M; Corcos J; Bismar TA
BJU Int; 2010 Aug; 106(3):418-23. PubMed ID: 20002675
[TBL] [Abstract][Full Text] [Related]
11. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
12. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-1 expression in locally invasive and metastatic prostate cancer.
Chen D; Adenekan B; Chen L; Vaughan ED; Gerald W; Feng Z; Knudsen BS
Urology; 2004 Feb; 63(2):402-7. PubMed ID: 14972511
[TBL] [Abstract][Full Text] [Related]
14. APPL1 is a multifunctional endosomal signaling adaptor protein.
Diggins NL; Webb DJ
Biochem Soc Trans; 2017 Jun; 45(3):771-779. PubMed ID: 28620038
[TBL] [Abstract][Full Text] [Related]
15. Altered endosome biogenesis in prostate cancer has biomarker potential.
Johnson IR; Parkinson-Lawrence EJ; Shandala T; Weigert R; Butler LM; Brooks DA
Mol Cancer Res; 2014 Dec; 12(12):1851-62. PubMed ID: 25080433
[TBL] [Abstract][Full Text] [Related]
16. Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer.
Szarvas T; Reis H; Vom Dorp F; Tschirdewahn S; Niedworok C; Nyirady P; Schmid KW; Rübben H; Kovalszky I
Prostate; 2016 Aug; 76(11):977-85. PubMed ID: 27062540
[TBL] [Abstract][Full Text] [Related]
17. Resistance training recovers attenuated APPL1 expression and improves insulin-induced Akt signal activation in skeletal muscle of type 2 diabetic rats.
Kido K; Ato S; Yokokawa T; Sato K; Fujita S
Am J Physiol Endocrinol Metab; 2018 Jun; 314(6):E564-E571. PubMed ID: 29406784
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Ström P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wählby C; Grönberg H; Rantalainen M; Egevad L; Eklund M
Lancet Oncol; 2020 Feb; 21(2):222-232. PubMed ID: 31926806
[TBL] [Abstract][Full Text] [Related]
19. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
[TBL] [Abstract][Full Text] [Related]
20. A systems-based modelling approach using transurethral resection of the prostate (TURP) specimens yielded incremental prognostic significance to Gleason when predicting long-term outcome in men with localized prostate cancer.
Donovan MJ; Khan FM; Bayer-Zubek V; Powell D; Costa J; Cordon-Cardo C
BJU Int; 2012 Jan; 109(2):207-13. PubMed ID: 21733075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
